Creepy Jar S.A. (CRJ.WA)
PLN 265.0
(-2.75%)
PLN 265.0
(-2.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 23.51 Million | 45.42 Billion | 35.5 Million | 25.07 Million | 5.53 Million | 442.12 Thousand |
| Net Income | 18.32 Million | 36.45 Billion | 29.1 Million | 22.4 Million | 139.45 Thousand | 2.2 Million |
| Depreciation & Amortization | 1.31 Million | 1.04 Billion | 1.59 Million | 1.14 Million | 4.6 Million | 182.81 Thousand |
| Deferred income taxes | - | -7.12 Million | - | - | - | - |
| Stock-based compensation | 4.54 Million | 7.12 Million | - | - | - | - |
| Change in working capital | 3.28 Million | 1.28 Billion | -1.34 Million | -4.33 Million | 724.39 Thousand | -1.94 Million |
| Other non-cash items | -3.74 Million | 6.63 Billion | 6.15 Million | 5.86 Million | 63.48 Thousand | -3552.45 |
| Investing Cash Flow | 56 Million | -84.89 Billion | -3.6 Million | -3.17 Million | -2.31 Million | -30.82 Thousand |
| Investments in PPE | -8.91 Million | -5.07 Billion | -3.67 Million | -3.29 Million | -2.31 Million | -30.82 Thousand |
| Acquisitions | 257.72 Thousand | - | - | - | - | - |
| Investment purchases | -37.16 Million | -103.57 Billion | - | - | - | - |
| Sales/Maturities of investments | 98 Million | 23.76 Billion | 70.62 Thousand | 123.83 Thousand | - | - |
| Other Investing Activities | 64.91 Million | -1000.00 | -1.00 | 0.46 | -0.49 | -2.13 Million |
| Financing Cash Flow | -25.56 Million | -14.78 Billion | -162.51 Thousand | -148.21 Thousand | - | 2 Million |
| Debt repayment | -328.85 Thousand | -156.7 Thousand | -148.73 Thousand | -148.21 Thousand | - | - |
| Dividends payments | -27.97 Million | -14.6 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.77 Million | - | - | - | - | 2 Million |
| Other Financing Activities | 2.74 Million | -178.75 Million | -13.77 Thousand | 0.30 | - | 2 Million |
| Accounts receivables | 3.18 Million | 765.72 Thousand | -2.23 Million | -2.09 Million | 565.89 Thousand | -1.51 Million |
| Accounts payables | 262.84 Thousand | 911.43 Thousand | - | 1.07 Million | 329.51 Thousand | 199.1 Thousand |
| Inventory | - | - | - | -9.75 Million | 3252.03 | -1.97 Million |
| Other working capital | 103.25 Thousand | 1.28 Billion | 882.22 Thousand | 6.43 Million | -174.26 Thousand | 36.01 Thousand |
| Cash at beginning of period | 5.48 Million | 59.73 Billion | 27.99 Million | 6.23 Million | 3.02 Million | 609.8 Thousand |
| Cash at end of period | 59.44 Million | 5.48 Billion | 59.73 Million | 27.99 Million | 6.23 Million | 3.02 Million |
| Capital Expenditure | -8.91 Million | -5.07 Billion | -3.67 Million | -3.29 Million | -2.31 Million | -30.82 Thousand |
| Effect of forex changes on cash | - | 1000.00 | - | 0.60 | - | 0.40 |
| Net cash flow / Change in cash | 53.95 Million | -54.25 Billion | 31.74 Million | 21.75 Million | 3.21 Million | 2.41 Million |
| Free Cash Flow | 14.6 Million | 40.34 Billion | 31.83 Million | 21.78 Million | 3.21 Million | 411.29 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.81 Million | 3.31 Million | 18.32 Million | -787.77 Thousand | 6.31 Million | 3.5 Million |
| Depreciation & Amortization | 342.48 Thousand | 354.03 Thousand | 1.31 Million | 336.66 Thousand | 299.86 Thousand | 313.62 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 4.54 Million | 2.27 Million | 2.27 Million | - |
| Change in working capital | 712.63 Thousand | -600.41 Thousand | 3.28 Million | 1.68 Million | -94.69 Thousand | 573.49 Thousand |
| Other non-cash items | -266.18 Thousand | -103.71 Thousand | -3.74 Million | -421.09 Thousand | -414.49 Thousand | -1.61 Million |
| Investing Cash Flow | 2.65 Million | -2.88 Million | 56 Million | -954.87 Thousand | 5.81 Million | 60.81 Million |
| Investments in PPE | -3.21 Million | -3.22 Million | -8.91 Million | -1.35 Million | -2.79 Million | -3.09 Million |
| Acquisitions | - | - | 257.72 Thousand | - | 2.79 Million | 3.09 Million |
| Investment purchases | -13.78 Million | -9.8 Million | -37.16 Million | - | -9.83 Million | -19.33 Million |
| Sales/Maturities of investments | 19.5 Million | 10 Million | 98 Million | - | 18 Million | 83.24 Million |
| Other Investing Activities | -3.06 Million | 338.06 Thousand | 64.91 Million | 402.21 Thousand | -2.35 Million | -3.09 Million |
| Financing Cash Flow | -9.3 Million | -83.78 Thousand | -25.56 Million | -84.29 Thousand | -28.16 Million | 2.72 Million |
| Debt repayment | -118.86 Thousand | -68.33 Thousand | -328.85 Thousand | - | -182.52 Thousand | -40.56 Thousand |
| Dividends payments | -9.16 Million | - | -27.97 Million | -13.98 Million | -27.97 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 2.77 Million | - | - | 2.77 Million |
| Other Financing Activities | -9.3 Million | -15.44 Thousand | 2.74 Million | -84.29 Thousand | -3796.00 | -44.48 Thousand |
| Accounts receivables | 126.97 Thousand | -126.43 Thousand | 3.18 Million | 3.18 Million | 434.24 Thousand | 1.97 Million |
| Accounts payables | - | - | 262.84 Thousand | - | - | -896.24 Thousand |
| Inventory | 25.55 Thousand | -28.27 Thousand | - | 665.98 Thousand | -5983.00 | -248.96 Thousand |
| Other working capital | 560.1 Thousand | -445.7 Thousand | 103.25 Thousand | -2.16 Million | -88.71 Thousand | -252.05 Thousand |
| Cash at beginning of period | 60.61 Million | 59.44 Million | 5.48 Million | 55.33 Million | 71.57 Million | 5.25 Million |
| Cash at end of period | 58.83 Million | 60.61 Million | 59.44 Million | 59.44 Million | 55.33 Million | 71.57 Million |
| Capital Expenditure | -3.21 Million | -3.22 Million | -8.91 Million | -1.35 Million | -2.79 Million | -3.09 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.77 Million | 1.17 Million | 53.95 Million | 4.1 Million | -16.24 Million | 66.32 Million |
| Free Cash Flow | 1.65 Million | 917.65 Thousand | 14.6 Million | 3.79 Million | 3.31 Million | -318 Thousand |
600754
NEOGEN
BNGRF
009520
1647
SR